MHRA authorises cancer treatment variation with an administration time of 3–5 minutesFeatured| MHRA| Nivolumab| under the skin injectionOn 30 April 2025, the Medicines and Healthcare Products Regulatory Agency (MHRA) approved a new under-the-skin ...